Skip to main content
  • Home
  •  Synopsis Article Listing
  •  Distal Radial Artery Access in comparison to Forearm Radial Artery Access for Cardiac Catheterization: A Randomized Controlled Trial (DARFORA Trial)

Distal Radial Artery Access in comparison to Forearm Radial Artery Access for Cardiac Catheterization: A Randomized Controlled Trial (DARFORA Trial)

Key Messages:

  • In regular, routine practice for coronary procedures, conventional radial access is often utilised. However, in cardiac procedures, the distal active site has now become popular.  

  • This study aims to evaluate feasibility, outcomes and complications in distal radial access compared with standard forearm radial access (FRA)  

  • The distal radial method in cardiac catheterisation seems to be demonstrating encouraging results. It is achievable and safe for both coronary angiography and interventions. However, the success rate is reliant on the patient’s selection and the operator’s expertise 

Study Design:

This single centre, parallel-group, partially blinded, randomised controlled trial was performed between December 2019 and December 2020, with a 1:1 allocation ratio (NCT04125992). A total of 209 patients were randomised into two groups: distal radial access (DRA) group (n =104) and FRA group (n = 105). 

Primary endpoint:

  • Success of the access puncture, which is defined as sheath insertion in the radial artery 

Other endpoints:

  • Puncture time, which is the time in seconds between the first and successful puncture attempt 

Inclusion criteria:

  • All patients who were hospitalised for cardiac catheterisation and had palpable proximal and distal radial pulses were included in the study 

Findings:

  • Regarding the baseline characteristics the groups were comparable in terms of age, gender, weight, and height 

  • In both groups, access was successful in 98% of patients (P=0.992) 

  • The DRA group displayed a lengthier puncture duration and an increased number of attempts (duration: 56.3 ± 58.3 s DRA vs. 20.0 ± 18.4 FRA, P<0.001, attempts: 1.9 ± 1.2 DRA vs. 1.2 ± 0.6 FRA, P<0.001). 

  • Greater puncture-associated pain was shown in the DRA group (4 ±2.2 DRA vs. 3 ± 2.1 FRA, P=0.001).  

  • Radial artery occlusions were evident in the FRA group (n=2) and there were none present in the DRA group (P=0.139) 

Conclusion:

DRA is a safe and practical alternative to FRA for coronary angiography and intervention. This study evidenced a high success rate, although this also presented an increase in puncture time, attempts, and pain. Nevertheless, shorter procedure times, fluoroscopy times, and hemostasis times were reported.

Limitations:

  • Single center 

  • Small sample size 

  • Patients were excluded from the study with STEMI and access side restriction due to prior CABG surgery and AVF  

  • Did not employ ultrasound guidance for arterial puncture 

  • Blind puncture increases the chances of tendon damage and hematoma formation 

Related Content

TIO 2023 – Symposium: Lifetime Patient Management Greater Expectations: Is TAVI Rising to The Challenge?
  • 1.00 EBAC

Learning objectives

  • Recall the latest data on durability and clinical outcomes for TAVI
  • Understand how TAVI is advancing and become aware of future treatment options for lifetime management of patients with aortic valve disease
  • Become more confident using TAVI in cases with complex anatomy
See more
Individualising Antithrombotic Strategies for Established CAD
  • 1.00 EBAC

Learning objectives

  • Summarise current guidance for choosing antithrombotic therapy in established CAD
  • Describe current gaps in clinical evidence and what is missing from current guidance
  • Adopt an evidence-based approach for managing patients with ACS and CCS
See more
Transcatheter Edge-to-Edge Repair: An Assessment of its Long-term Impact on Mitral Regurgitation
  • 1.00 EBAC

Learning objectives

  • Recall the long-term outcomes of TEER from real-world and RCT data
  • Apply the results of real-world data to both simple and complex patients
  • Describe how TEER is being used to benefit a range of patients with MR
See more
Severe Aortic Stenosis: Stratifying Patients for Lifetime Management
  • 1.00 EBAC

Learning objectives

  • Describe the challenges with lifetime management in severe AS in both a SAVR and TAVI-first scenario
  • Summarise clinical evidence for TAVI in low surgical risk patients
  • Recall different guideline recommendations for SAVR and TAVI approaches
  • Assimilate current clinical knowledge with patient preferences when formulating treatment plans for severe AS patient
See more
Renal Denervation In The Real World: Practical Guidance For New Users
  • 1.00 EBAC

Learning objectives

  • Assess the current global burden of resistant hypertension
  • Carry out appropriate assessments to identify resistant hypertension
  • Identify patients most likely to benefit from RDN
  • Recall the practical considerations for adopting RDN into routine practice
  • Recall the latest data on RDN from recent clinical trials
See more
Getting it Right First Time in Severe Aortic Stenosis - Key insights for Long Term Success
  • 1.00 EBAC

Learning objectives

  • Recall current and predicted trends in TAVI with respect to preserving coronary access
  • Consider determining factors for choosing valves in low risk populations
  • Discuss solutions for maximising valve durability and haemodynamics and for treating degenerated TAVI
See more
Optimising Outcomes For The TAVI Patient: Key Considerations For First Valve Choice And Implantation Techniques
  • Not accredited

Learning objectives

  • Recall the latest data showing why durability and hemodynamics matter for initial valve selection
  • Discuss the latest techniques to help achieve optimal outcomes for patients with longer life expectancy
  • Review TAVI cases that highlight procedure optimisation with the Evolut pro+ platform
See more
TIO 2022 - Session 3.4: Debates
  • 1.00 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
TIO 2022 - Session 3.3: Keynote & Controversies: Live Cases And Discussion
  • 1.00 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
TIO 2022 - Session 3.1 & 3.2: Keynote & Controversies
  • 1.00 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more